These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 31662734)

  • 1. Optimizing Secukinumab Treatment in Psoriasis with Concomitant Methotrexate Administration: Minireview and A Case Report.
    Kostaki D; Aquila E; Macaluso L; Mattozzi C; Richetta AG
    Case Rep Dermatol; 2019; 11(Suppl 1):17-22. PubMed ID: 31662734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psoriasis: Which therapy for which patient: Psoriasis comorbidities and preferred systemic agents.
    Kaushik SB; Lebwohl MG
    J Am Acad Dermatol; 2019 Jan; 80(1):27-40. PubMed ID: 30017705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biologic Therapy Utilization in Patients With Moderate to Severe Psoriasis and Psoriatic Arthritis: An Observational Summary of Biologic Therapy Use in a Clinical Setting.
    Gulliver WP; Randell S; Gulliver S; Gregory V; Nagle S; Chambenoit O
    J Cutan Med Surg; 2018; 22(6):567-576. PubMed ID: 29952225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secukinumab: a review of the anti-IL-17A biologic for the treatment of psoriasis.
    Frieder J; Kivelevitch D; Menter A
    Ther Adv Chronic Dis; 2018 Jan; 9(1):5-21. PubMed ID: 29344327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secukinumab-Induced Inflammatory Bowel Disease in a Patient Treated for Chronic Plaque Psoriasis and Psoriatic Arthritis: A Case Report and Review of the Role of Novel Biologic Agents Targeting the p19 Subunit of IL-23.
    Darch KM; Holland TL; Spelman LJ
    Case Rep Med; 2020; 2020():9404505. PubMed ID: 32774388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apremilast and Secukinumab Combined Therapy in a Patient With Recalcitrant Plaque Psoriasis.
    Rothstein BE; McQuade B; Greb JE; Goldminz AM; Gottlieb AB
    J Drugs Dermatol; 2016 May; 15(5):648-9. PubMed ID: 27168275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infliximab in psoriasis and psoriatic arthritis.
    Papoutsaki M; Osório F; Morais P; Torres T; Magina S; Chimenti S; Costanzo A
    BioDrugs; 2013 Jan; 27 Suppl 1():13-23. PubMed ID: 23990278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful therapy of plaque-type psoriasis with secukinumab in patients with multiple comorbidities treated with previous biologic therapies.
    Lasagni C; Bigi L; Conti A; Pellacani G
    J Dermatolog Treat; 2018; 29(sup2):5-8. PubMed ID: 30403898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secukinumab treatment of moderate to severe plaque psoriasis in routine clinical care: real-life data of prior and concomitant use of psoriasis treatments from the PROSPECT study.
    Körber A; Thaçi D; von Kiedrowski R; Bachhuber T; Melzer N; Kasparek T; Kraehn-Senftleben G; Amon U; Augustin M
    J Eur Acad Dermatol Venereol; 2018 Mar; 32(3):411-419. PubMed ID: 28960469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secukinumab efficacy in the treatment of nail psoriasis: a case series.
    Pistone G; Gurreri R; Tilotta G; Castelli E; Bongiorno MR
    J Dermatolog Treat; 2018; 29(sup1):21-24. PubMed ID: 30273068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of etanercept in psoriasis after switching from other treatments: an observational study.
    Mazzotta A; Esposito M; Costanzo A; Chimenti S
    Am J Clin Dermatol; 2009; 10(5):319-24. PubMed ID: 19658444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment challenges in the management of moderate-to-severe plaque psoriasis - role of secukinumab.
    Malakouti M; Jacob SE; Anderson NJ
    Clin Cosmet Investig Dermatol; 2016; 9():347-355. PubMed ID: 27785085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Profile of secukinumab in the treatment of psoriasis: current perspectives.
    Roman M; Madkan VK; Chiu MW
    Ther Clin Risk Manag; 2015; 11():1767-77. PubMed ID: 26664127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secukinumab: A New Treatment Option for Psoriatic Arthritis.
    Mease P; McInnes IB
    Rheumatol Ther; 2016 Jun; 3(1):5-29. PubMed ID: 27747518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secukinumab induction and maintenance therapy in moderate-to-severe plaque psoriasis: a randomized, double-blind, placebo-controlled, phase II regimen-finding study.
    Rich P; Sigurgeirsson B; Thaci D; Ortonne JP; Paul C; Schopf RE; Morita A; Roseau K; Harfst E; Guettner A; Machacek M; Papavassilis C
    Br J Dermatol; 2013 Feb; 168(2):402-11. PubMed ID: 23362969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biologics use in Indian psoriasis patients.
    Rajagopalan M; Mital A
    Indian Dermatol Online J; 2016; 7(6):489-497. PubMed ID: 27990383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secukinumab Improves Physical Function in Subjects With Plaque Psoriasis and Psoriatic Arthritis: Results from Two Randomized, Phase 3 Trials.
    Gottlieb AB; Langley RG; Philipp S; Sigurgeirsson B; Blauvelt A; Martin R; Papavassilis C; Mpofu S
    J Drugs Dermatol; 2015 Aug; 14(8):821-33. PubMed ID: 26267726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Etanercept and infliximab for the treatment of psoriatic arthritis: a systematic review and economic evaluation.
    Woolacott N; Bravo Vergel Y; Hawkins N; Kainth A; Khadjesari Z; Misso K; Light K; Asseburg C; Palmer S; Claxton K; Bruce I; Sculpher M; Riemsma R
    Health Technol Assess; 2006 Sep; 10(31):iii-iv, xiii-xvi, 1-239. PubMed ID: 16948890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythrodermic Psoriasis Treated with Golimumab: A Case Report.
    Lee WK; Kim GW; Cho HH; Kim WJ; Mun JH; Song M; Kim HS; Ko HC; Kim MB; Kim BS
    Ann Dermatol; 2015 Aug; 27(4):446-9. PubMed ID: 26273164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination Therapy of Apremilast and Biologic Agent as a Safe Option of Psoriatic Arthritis and Psoriasis.
    Metyas S; Tomassian C; Messiah R; Gettas T; Chen C; Quismorio A
    Curr Rheumatol Rev; 2019; 15(3):234-237. PubMed ID: 30499418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.